Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2006-09-12
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252100, C514S299000, C514S337000, C514S365000, C514S393000, C514S406000, C514S443000, C544S131000, C544S146000, C544S405000, C546S112000, C546S279100, C546S281100, C548S200000, C548S311400, C548S364400, C549S057000
Reexamination Certificate
active
07105513
ABSTRACT:
The present invention relates to acylated, heteroaryl-condensed cycloalkenylamines, to pharmaceutical compositions comprising such compounds, to methods for the stimulation of the expression of endothelial NO synthase, and methods of treatment comprising administering such compounds.
REFERENCES:
patent: 5075303 (1991-12-01), Cliffe et al.
patent: 5527815 (1996-06-01), Tomiyama et al.
patent: 5753662 (1998-05-01), Peglion et al.
patent: 6048880 (2000-04-01), Kawai et al.
patent: 6258829 (2001-07-01), Takahashi et al.
patent: 6278027 (2001-08-01), Tomiyama et al.
patent: 6410561 (2002-06-01), Shinkai et al.
patent: 6617359 (2003-09-01), Strobel
patent: 6696470 (2004-02-01), Kawai et al.
patent: 6759412 (2004-07-01), Strobel
patent: 6812253 (2004-11-01), Strobel
patent: 6949556 (2005-09-01), Strobel
patent: 2003/0022935 (2003-01-01), Strobel
patent: 2003/0055087 (2003-03-01), Shinkai et al.
patent: 2003/0055093 (2003-03-01), Strobel
patent: 2004/0082628 (2004-04-01), Strobel
patent: 2004/0110808 (2004-06-01), Strobel
patent: 2004/0142976 (2004-07-01), Kawai et al.
patent: 2004/0225013 (2004-11-01), Strobel
patent: 2005/0054729 (2005-03-01), Strobel
patent: 2005/0101599 (2005-05-01), Zeiher
patent: 2151443 (1995-09-01), None
patent: 02-255664 (1990-10-01), None
patent: 08-325234 (1996-12-01), None
patent: WO 99/47153 (1999-09-01), None
patent: WO 00/03746 (2000-01-01), None
patent: WO 01/68652 (2001-09-01), None
Duda et al.I, Trends in Molecular Medicine, 10(4), 143-145, Apr. 2004.
Endres et al, Trends in Neurosciences, 27(5), 283-289, May 2004.
Li et al, Nitric Oxide, 7, 149-164, 2002.
Sase et al, Trends in Cardiovascular Medicine, 7(1), 28-37, Jan. 1997.
Bianchi, et al., Regioselectivity in the Reactions of Benzonitrite N-Phenyl-Imide and Some Benzonitrite N-Oxides with a,B-Unsaturated Ketones., J. Chem. Res, Synop. (1981) 6-7.
Binder, et al., A Facile Route to Functionalized Cyclopenta [b] thiophenones Based on the Structure of the Selective COX-2 Inhibitor Flosulide, Monatsh. Chem 129, (1998), 887-896.
Caprathe, et al., Dopamine Autoreceptor Agonists as Potential Antipsychotics. 3. 1 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo [4,5-f] quinolin-2-amine, J. Med. Chem. 34, (1991), 2736-2746.
Dammertz, et al., Synthase Von 6,7,8,9-Tetrahydro-5H-cyclohepta[b] pyridin-5-on, Arch. Pharm. 310 (1977), 172-176.
Endres, et al. , Stroke Protection By 3-Hydroxy-3-Methylglutaryl (HMG)—CoA Reductase Inhibitors Medicated By Endothelial Nitric Oxide Synthase, Proc. Natl. Acad. Sci. USA, 95 (1998) 8880-8885.
Hicks, et al., The Synthesis And Photochemical Behaviour Of Some Annelated Tropones, J. Chem. Soc. Perkin Trans. 1, (1984) 2297-2304.
Hoffman, et al., Synthesis Of 3-Nitro-5-Acylpyridines By Condensation Of Sodium Nitromalonaldehyde/Tosyl Chloride With 2-Amino-1-Acyl Olefins. Evidence For the Intermediacy of 3-Chloro-2-Nitroacrolein, J. Org. Chem. 49 (1984), 193-195.
Huang, et al., The Improved Preparation Of 7,8-Dihydro-Quinoline-5(6H)-One and 6,7-Dihydro-5H-1-Pyrindin-5-One, Synth. Commun. 28 (1998), 1197-1200.
Jones, et al., Synthesis Of 4-H-Cyclohepta [b] thiophen-4-ones, 4H-Cyclohepta [b] furna-4-one, and 9H-Cyclohepta[b] pyridin-9-one, J. Chem. Soc., Perkin Trans., 1, (1973), 968-972.
Koehler, et al., Potential Anticancer Agents IX. Tetrahydroquinazoline Analogs Of Tetrahydrofolic Acid. I, J. Am. Chem. Soc. 80 (1958) 5779-5785.
Li, et al., Activation Of Protein Kinase Ca and/or e Enhances Transcription of the Human Endothelial Nitric Oxide Synthase Gene, Mol. Pharmacol. 53 (1998) 630-637.
MacDowell, et al., The Use Of 2,5-Dichlorothiophene in The Synthesis Of 3,4-Disubstituted Thiophenes, J. Org. Chem. Soc. 32 (1967) 1226-1229.
Moroi, et al. , Interaction of Genetic Deficiency of Endothelial Nitric Oxide, Gender, and Pregnancy in Vascular Response to Injury in Mice, J. Clin. Invest., 101 (1998) 1225-1232.
Muraro, et al., Heterocycles sulfures condenses.—Synthese et dechloration de dichloro-1,3 thieno (c) cyclenones,, Bull. Soc. Chim. Fr., Pt. 2, (1973) 335-342.
Muraro, et al., Recherches dans le domaine des thieno (c) cyclenones. , C.R. Acad. Sci., Ser. C, 273 (1971) 1362-1367.
Nakayama, et al., T- 786—C Mutation in the 5′ -Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm, Circulation 99 (1999) 2864-2870.
Nayyar, et al., New Approach for the General Synthesis of Oxotetrahydroindoles via Intramolecular Cycloadditions of Azomethine Ylides with Tethered Alkynes, J. Org. Chem. 62 (1997) 982-991.
Ravina, et al., Conformationally Constrained Butyrophenones with Mixed Dopaminergic (D2) and Serotoninergic (5-HT2A, 5-HT2C) Affinities: Synthesis, Pharmacology, 3D-QSAR, and Molecular Modeling of (Aminoalkyl) benzo- and—thienocycloalkanones as Putative Atypical Antipsychotics, J. Med. Chem. 42 (1999) 2774-2797.
Reimann, et al., Regioselektive Synthase von 4-Methyl-1-pyridin-5-on, Pharmazie 50 (1995) 589-592.
Ruangsiyanand, et al., Enamine Cyclischer 1.3-Diketone als Ausgangsstoffe fur Pyridinringsynthesen, Chem. Ber. 103 (1970) 2403-2410.
Schenone, et al. , Reaction of 2-Dimethylaminomethylene-1,3-diones with Dinucleophiles. I. Synthesis of 1,5-Disubstituted 4-Acylpyrazoles, J. Heterocyclic Chem., 19 (1982) 1355-1361.
Schroeder, et al., Nichtsteroldale Entzundungshemmer. 3. Substituierte Aza-Tetralin—und Aza-indancarbonsauren Mit Antiphlogistischer Wirkung, J. Med. Chem.—Chim. Ther. 14 (1979) 309-315.
Sessa, et al., Chronic Exercise In Dogs Increases Coronary Vascular Nitric Oxide Production And Endothelial Cell Nitric Oxide Synthase Gene Expression, Circ. Research 74 (1994) 349-353.
Shigeki, et al., 7-Oxocyclopenta[d]Pyrimidine Derivative, esp@cenet database—12 -Document Bibliography and Abstract, no date available.
Takeshi, et al., Benzoic Acid Derivative Or Its Salt, esp@cenet database -12—Document Bibliography and Abstract, no date available.
Varenne, et al. , Percutaneous Gene Therapy Using Recombinant Adenoviruses Encoding Human Herpes Simplex Virus Thymidine Kinase, Human PAI-1, and Human NOS3 in Balloon-Injured Porcine Coronary Arteries, Hum. Gene Ther. 11 (2000) 1329-1339.
Westerwelle, et al., B-Aminoketone als Schlusselverbindungen zur Synthase von Pyridinen: Eln Neuartiger, Leistungsfahiger Zugang zu Kondensierten Bi- und Terpyridinen, Chem. Ber. 124 (1991) 571-576.
Strobel Hartmut
Wohlfart Paulus
Darkes Paul
Lin Jiang
Powers Fiona T.
Sanofi-Avertis Deutschland GmbH
LandOfFree
Acylated, heteroaryl-condensed cycloalkenylamines and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated, heteroaryl-condensed cycloalkenylamines and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated, heteroaryl-condensed cycloalkenylamines and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549129